All the news Showing 10 of 38 articles.Get an RSS feed of these articles Show All news infohep newsEditors' picks from other sources HBV drug Tyzeka discontinued Healio Hepatology / 11 October 2016 New Tenofovir Formulation Provides Safer Hepatitis B Treatment Medscape (free registration required) / 03 October 2016 ContraVir Reports New CRV431 Data Highlighting Synergistic Activity with CMX157 Against Hepatitis B ContraVir press release / 12 September 2016 Antiviral therapy prolongs survival in immune tolerant hepatitis B patients Eurekalert Inf Dis / 15 April 2016 Treatment for chronic hepatitis B linked to increased rates of colorectal and cervical cancer EASL press release / 15 April 2016 ContraVir's CMX157 Outperforms Gilead's Tenofovir AF (TAF) Against Hepatitis B Virus in Independent Head-to-Head In-Vitro Study ContraVir press release / 30 March 2016 J&J signs deal with Chinese company for hepatitis B drug Reuters / 08 January 2016 Gilead Announces Top-Line Results From Two Phase 3 Studies Evaluating Tenofovir Alafenamide (TAF) for Patients With Chronic Hepatitis B Infection Gilead press release / 05 January 2016 Cancer drug shows promise as cure for hepatitis B Science Daily / 21 April 2015 Arrowhead initiates phase 2b trial for potential HBV drug Healio Hepatology / 14 April 2015 ← Prev1234Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive